UBS Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.5M | Sell |
270,400
-43,200
| -14% | -$4.99M | ﹤0.01% | 2089 |
|
|
2025
Q4 | $33M | Sell |
313,600
-275,746
| -47% | -$25.9M | 0.01% | 2069 |
|
|
2025
Q3 | $49.5M | Buy |
589,346
+8,976
| +2% | +$739K | 0.01% | 1631 |
|
|
2025
Q2 | $45.9M | Sell |
580,370
-180,300
| -24% | -$14.3M | 0.01% | 1602 |
|
|
2025
Q1 | $68.3M | Buy |
760,670
+71,300
| +10% | +$6.66M | 0.01% | 1194 |
|
|
2024
Q4 | $68.6M | Sell |
689,370
-55,500
| -7% | -$5.72M | 0.01% | 1192 |
|
|
2024
Q3 | $84.6M | Buy |
744,870
+271,594
| +57% | +$32.3M | 0.02% | 822 |
|
|
2024
Q2 | $58.6M | Sell |
473,276
-73,894
| -14% | -$9.52M | 0.01% | 927 |
|
|
2024
Q1 | $72.2M | Sell |
547,170
-327,189
| -37% | -$40.3M | 0.02% | 823 |
|
|
2023
Q4 | $95.3M | Buy |
874,359
+364,259
| +71% | +$37.8M | 0.03% | 589 |
|
|
2023
Q3 | $52.5M | Buy |
510,100
+35,000
| +7% | +$3.77M | 0.02% | 815 |
|
|
2023
Q2 | $54.8M | Sell |
475,100
-76,700
| -14% | -$8.71M | 0.02% | 779 |
|
|
2023
Q1 | $58.7M | Sell |
551,800
-7,500
| -1% | -$810K | 0.02% | 699 |
|
|
2022
Q4 | $62.1M | Buy |
559,300
+52,400
| +10% | +$5.36M | 0.02% | 698 |
|
|
2022
Q3 | $43.7M | Buy |
506,900
+180,000
| +55% | +$16.1M | 0.02% | 765 |
|
|
2022
Q2 | $29.8M | Buy |
326,900
+71,700
| +28% | +$6.36M | 0.01% | 1065 |
|
|
2022
Q1 | $20.9M | Sell |
255,200
-10,400
| -4% | -$820K | 0.01% | 1384 |
|
|
2021
Q4 | $20.4M | Buy |
265,600
+200,701
| +309% | +$16M | 0.01% | 1571 |
|
|
2021
Q3 | $4.88M | Buy |
64,899
+46,993
| +262% | +$3.57M | ﹤0.01% | 2699 |
|
|
2021
Q2 | $1.39M | Sell |
17,906
-113,663
| -86% | -$8.45M | ﹤0.01% | 3900 |
|
|
2021
Q1 | $9.68M | Buy |
131,569
+10,001
| +8% | +$738K | ﹤0.01% | 1978 |
|
|
2020
Q4 | $9.49M | Sell |
121,568
-2,620
| -2% | -$200K | ﹤0.01% | 1891 |
|
|
2020
Q3 | $9.83M | Buy |
124,188
+61,518
| +98% | +$4.82M | ﹤0.01% | 1655 |
|
|
2020
Q2 | $4.62M | Sell |
62,670
-5,660
| -8% | -$426K | ﹤0.01% | 2109 |
|
|
2020
Q1 | $5.02M | Sell |
68,330
-78,076
| -53% | -$6.14M | ﹤0.01% | 1930 |
|
|
2019
Q4 | $12.7M | Buy |
146,406
+39,510
| +37% | +$3.25M | ﹤0.01% | 1730 |
|
|
2019
Q3 | $8.59M | Buy |
106,896
+75,142
| +237% | +$6.02M | ﹤0.01% | 1890 |
|
|
2019
Q2 | $2.54M | Sell |
31,754
-314,400
| -91% | -$24.1M | ﹤0.01% | 2929 |
|
|
2019
Q1 | $27.5M | Buy |
346,154
+337,162
| +3,750% | +$25.2M | 0.01% | 957 |
|
|
2018
Q4 | $656K | Sell |
8,992
-87,917
| -91% | -$6.21M | ﹤0.01% | 4052 |
|
|
2018
Q3 | $6.56M | Buy |
96,909
+71,728
| +285% | +$4.57M | ﹤0.01% | 2116 |
|
|
2018
Q2 | $1.46M | Sell |
25,181
-53,838
| -68% | -$3.04M | ﹤0.01% | 3446 |
|
|
2018
Q1 | $4.11M | Sell |
79,019
-126,075
| -61% | -$6.81M | ﹤0.01% | 2495 |
|
|
2017
Q4 | $11M | Buy |
205,094
+97,616
| +91% | +$5.41M | ﹤0.01% | 1641 |
|
|
2017
Q3 | $6.57M | Buy |
+107,478
| New | +$6.52M | ﹤0.01% | 1956 |
|
|
2017
Q2 | – | Sell |
-44,802
| Closed | -$2.72M | – | 7862 |
|
|
2017
Q1 | $2.72M | Sell |
44,802
-349,005
| -89% | -$21.2M | ﹤0.01% | 2647 |
|
|
2016
Q4 | $22.1M | Buy |
393,807
+250,231
| +174% | +$14.6M | 0.01% | 962 |
|
|
2016
Q3 | $8.55M | Sell |
143,576
-18,204
| -11% | -$1.06M | 0.01% | 1547 |
|
|
2016
Q2 | $8.89M | Buy |
161,780
+76,263
| +89% | +$4.06M | 0.01% | 1473 |
|
|
2016
Q1 | $4.32M | Buy |
85,517
+48,574
| +131% | +$2.38M | ﹤0.01% | 1994 |
|
|
2015
Q4 | $1.86M | Buy |
36,943
+473
| +1% | +$23.8K | ﹤0.01% | 2857 |
|
|
2015
Q3 | $1.72M | Sell |
36,470
-49,776
| -58% | -$2.64M | ﹤0.01% | 2880 |
|
|
2015
Q2 | $4.68M | Sell |
86,246
-72,736
| -46% | -$4.08M | ﹤0.01% | 2143 |
|
|
2015
Q1 | $8.72M | Sell |
158,982
-8,803
| -5% | -$498K | 0.01% | 1583 |
|
|
2014
Q4 | $9.09M | Buy |
+167,785
| New | +$9.35M | 0.01% | 1581 |
|
Other funds holding MRK
VCM
VPM
UBS Group's MRK Position: Q1 2026 in Review
UBS Group reduced its Merck (MRK) stake by 27% in Q1 2026, selling an estimated $605M and leaving 13,933,630 shares worth $1.68B. The position accounts for 0.25% of the portfolio, ranked #65.
UBS Group first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.02B in Q4 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- UBS Group held 13,933,630 shares of Merck worth $1.68B as of Q1 2026.
- UBS Group sold 5,244,642 Merck shares in Q1 2026, an estimated $605M.
- Merck made up 0.25% of UBS Group's portfolio in Q1 2026, its #65 holding.
- UBS Group first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Merck position peaked at $2.02B in Q4 2025.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.